Company Overview:
Saluda is a global healthcare company that is redefining Spinal Cord Stimulation (SCS) therapy at the intersection of automated algorithms, real-time diagnostics, and ground-breaking clinical evidence. The Saluda difference is defined by Dose-Control Technology via measurement of physiological response.
At Saluda, we challenge boundaries. We innovate and think beyond the conventional. We disrupt. With the passion and energy of an accomplished team of seasoned experts, our focus is to revolutionize the standard of care in the neuromodulation space by transforming the lives of patients suffering from debilitating pain.
The Role:
The Head of Market Access & Reimbursement Strategy plays a critical role in the development and execution of patient access, reimbursement and adoption strategies globally. As a subject matter expert with proven track record of functional success, the Director will inform access policy with support and collaboration with key constituencies within and outside of the company. He or she will engage with key decision makers and have demonstrated expertise working with agencies including the U.S. Center for Medicare & Medicaid Services, and private payers. Working closely with internal stakeholders, this individual will further inform product development, from conception and throughout the product development life cycle. In addition, the role will be responsible for managing a patient access program, driving differentiation in the field through market access initiatives, and monitoring government policy changes.
Responsibilities:
Essential Requirements:
Saluda Medical embraces diversity and equal opportunity. We are committed to building a team representative of a variety of backgrounds, perspectives and skills. We believe people are the source of our inspiration and innovation.
Saluda Medical does not accept non-solicited resumes or candidate submittals from search/recruiting agencies not already on Saluda Medical’s approved agency list. Unsolicited resumes or candidate information submitted to Saluda Medical by search/recruiting agencies not already on Saluda Medical’s approved agency list shall become the property of Saluda Medical.
Atlassian
Wisevu
Marshalls PLC
Fortinet
Thermo Fisher Scientific